Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates, Hua-Xin Liao, Youyi Fong, et al.
Science Translational Medicine (2014) Vol. 6, Iss. 228
Open Access | Times Cited: 430

Showing 1-25 of 430 citing articles:

The role of IgG Fc receptors in antibody-dependent enhancement
Stylianos Bournazos, Aaron Gupta, Jeffrey V. Ravetch
Nature reviews. Immunology (2020) Vol. 20, Iss. 10, pp. 633-643
Open Access | Times Cited: 473
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung, Musie Ghebremichael, Hannah R. Robinson, et al.
Science Translational Medicine (2014) Vol. 6, Iss. 228
Closed Access | Times Cited: 379
Antibody responses to envelope glycoproteins in HIV-1 infection
Dennis R. Burton, John R. Mascola
Nature Immunology (2015) Vol. 16, Iss. 6, pp. 571-576
Open Access | Times Cited: 369
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
Amy W. Chung, Manu P. Kumar, Kelly B. Arnold, et al.
Cell (2015) Vol. 163, Iss. 4, pp. 988-998
Open Access | Times Cited: 341
The Immunoregulatory Roles of Antibody Glycosylation
Madeleine F. Jennewein, Galit Alter
Trends in Immunology (2017) Vol. 38, Iss. 5, pp. 358-372
Closed Access | Times Cited: 289
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Margaret E. Ackerman, Anastassia Mikhailova, Eric P. Brown, et al.
PLoS Pathogens (2016) Vol. 12, Iss. 1, pp. e1005315-e1005315
Open Access | Times Cited: 227
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Matthew Zirui Tay, Kevin Wiehe, Justin Pollara
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 204
Immune correlates of vaccine protection against HIV-1 acquisition
Lawrence Corey, Peter B. Gilbert, Georgia D. Tomaras, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 310
Open Access | Times Cited: 196
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
Eric P. Brown, Karen Dowell, Austin W. Boesch, et al.
Journal of Immunological Methods (2017) Vol. 443, pp. 33-44
Open Access | Times Cited: 186
Role of IgG3 in Infectious Diseases
Timon Damelang, Stephen J. Rogerson, Stephen J. Kent, et al.
Trends in Immunology (2019) Vol. 40, Iss. 3, pp. 197-211
Open Access | Times Cited: 172
Vaccination induces HIV broadly neutralizing antibody precursors in humans
David J. Leggat, Kristen W. Cohen, Jordan R. Willis, et al.
Science (2022) Vol. 378, Iss. 6623
Open Access | Times Cited: 157
FcγR Binding and ADCC Activity of Human IgG Allotypes
Steven W. de Taeye, Arthur E. H. Bentlage, Mirjam M. Mebius, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 144
Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection
Jérôme H. Kim, Jean‐Louis Excler, Nelson L. Michael
Annual Review of Medicine (2014) Vol. 66, Iss. 1, pp. 423-437
Open Access | Times Cited: 170
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response
James J. Knox, Marcus Buggert, Lela Kardava, et al.
JCI Insight (2017) Vol. 2, Iss. 8
Open Access | Times Cited: 169
HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions
Cody S. Nelson, Tori Huffman, Jennifer A. Jenks, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 24, pp. 6267-6272
Open Access | Times Cited: 150
B‐cell responses to HIV infection
Susan Moir, Anthony S. Fauci
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 33-48
Open Access | Times Cited: 145
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques
Sampa Santra, Georgia D. Tomaras, Ranjit Warrier, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 8, pp. e1005042-e1005042
Open Access | Times Cited: 144
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
Todd Bradley, Justin Pollara, Sampa Santra, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 133
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV
Margaret E. Ackerman, Jishnu Das, Srivamshi Pittala, et al.
Nature Medicine (2018) Vol. 24, Iss. 10, pp. 1590-1598
Open Access | Times Cited: 132
Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity in HIV-Infected Infants Is Associated with Reduced Mortality
Caitlin Milligan, Barbra A. Richardson, Grace John‐Stewart, et al.
Cell Host & Microbe (2015) Vol. 17, Iss. 4, pp. 500-506
Open Access | Times Cited: 126
Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions
Tiza L Nguni, Caroline Chasara, Zaza M. Ndhlovu
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 126
Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses
Matthew Zirui Tay, Pinghuang Liu, LaTonya D. Williams, et al.
PLoS Pathogens (2016) Vol. 12, Iss. 8, pp. e1005817-e1005817
Open Access | Times Cited: 118
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
Linda‐Gail Bekker, Zoe Moodie, Nicole Grunenberg, et al.
The Lancet HIV (2018) Vol. 5, Iss. 7, pp. e366-e378
Open Access | Times Cited: 116
Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
Mireia Pelegrín, Mar Naranjo‐Gómez, Marc Piechaczyk
Trends in Microbiology (2015) Vol. 23, Iss. 10, pp. 653-665
Open Access | Times Cited: 112
Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines
Jean‐Louis Excler, Julie A. Ake, Merlin L. Robb, et al.
Clinical and Vaccine Immunology (2014) Vol. 21, Iss. 8, pp. 1023-1036
Open Access | Times Cited: 111
Page 1 - Next Page

Scroll to top